Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis-Reference-Cited by-同舟云学术

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis

Published:2012-12-12 Issue:9 Volume:72 Page:1445-1452
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Burmester Gerd R,Weinblatt Michael E,McInnes Iain B,Porter Duncan,Barbarash Olga,Vatutin Mykola,Szombati Istvan,Esfandiari Ehsanollah,Sleeman Matthew A,Kane Christopher D,Cavet Guy,Wang Bing,Godwood Alex,Magrini Fabio,

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference44 articles.

1. Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis;Campbell;Br J Pharmacol,2011

2. G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis;Cornish;Nat Rev Rheumatol,2009

3. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis;Mulherin;Arthritis Rheum,1996

4. Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers;Bresnihan;J Rheumatol,2007

5. Synovial tissue analysis for the discovery of diagnostic and prognostic biomarkers in patients with early arthritis;de Hair;J Rheumatol,2011

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunomodulatory of interleukin-33 in rheumatoid arthritis: A systematic review;Clinical Immunology;2024-08

2. Novel and potential future therapeutic options in systemic autoimmune diseases;Frontiers in Immunology;2024-03-15

3. An Update on the Emerging Role of Wnt/β-catenin, SYK, PI3K/AKT, and GM-CSF Signaling Pathways in Rheumatoid Arthritis;Current Drug Targets;2023-12

4. Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2);Annals of the Rheumatic Diseases;2023-09-12

5. Emerging aspects of cytokine storm in COVID-19: The role of proinflammatory cytokines and therapeutic prospects;Cytokine;2023-09